Overview

Directly Observed Therapy in High Risk Populations in Newark, NJ

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
30 patients with poor antiretroviral therapy compliance will be identified from our pool of patients at Saint Michael's Medical Center and be given Directly observed therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Saint Michael's Medical Center
Collaborator:
Hoffmann-La Roche
Treatments:
Saquinavir